Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.
A Cornell research group reports that a mechanical factor - stiffening of a cancer cell and its matrix - and not a chemical cause could contribute to metastasis in some forms of cancer.
The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine PSA testing.
Scientists from Weill Cornell Medicine discovered an internal code in cellular molecules, called messenger RNA, predetermines how much protein they will produce.
A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence, according to new research from Weill Cornell Medicine scientists.
Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.
An experimental drug that blocks the activation of an immune cell component effectively prevented rejection of heart transplants in mice, says new research from scientists at Weill Cornell Medicine.
A Weill Cornell Medicine study published Dec. 7 represents the first time scientists have captured the restoration of communication of a minimally conscious patient by measuring aspects of brain structure and function.